Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells

Journal of Virology

Volumn 75, Issue 15, 2001, Pages 6953-6961

  Forthal, D N ^a   Landucci, G ^a   Daar, E S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BETA CHEMOKINE; IMMUNOGLOBULIN G; VIRUS GLYCOPROTEIN;

ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; VIREMIA; VIRUS INHIBITION; VIRUS STRAIN;

ANTIBODY-DEPENDENT CELL CYTOTOXICITY; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV-1; HUMANS; KILLER CELLS, NATURAL; MACROPHAGE INFLAMMATORY PROTEIN-1; RANTES; VIREMIA;

EID: 0034958413     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.15.6953-6961.2001     Document Type: Article

References (39)

1. Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen
2. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
3. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
4. HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression
5. Passive infusion of immune serum into simian immunodeficiency virus-infected rhesus macaques undergoing a rapid disease course has minimal effect on plasma viremia
6. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
7. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
8. CD56 identifies monocytes and not natural killer cells in rhesus macaques
9. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells
10. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells
11. HIV-specific cellular and humoral immune responses in primary HIV infection
12. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection
13. + cells is mediated by the chemokine receptor CC-CKR-5
14. + lymphocyte count
15. Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus
16. Antibody-dependent cellular cytotoxicity against HIV-coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients
17. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
18. Course of specific T lymphocyte cytotoxicity, plasma and cellular viral loads, and neutralizing antibody titers in 17 recently seroconverted HIV type 1-infected patients
19. Cytotoxic T lymphocytes specific for the simian immunodeficiency virus
20. The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag. Pol, Env, and Nef proteins
21. Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack
22. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
23. Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals
24. Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1
25. Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells
26. In situ immunophenotyping of lymphocytes/macrophages: Grading of lymphadenopathy, staging and pathophysiology of HIV infection
27. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection
28. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro
29. Lymph node architecture preceding and following 6 months of potent antiviral therapy: Follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patient
30. Neutralizing antibody responses to human immunodeficiency virus type 1 in primary, infection and long-term-nonprogressive infection
31. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection
32. Alternative membrane forms of Fc gamma RIII (CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions
33. + T cell responses associated with control of viremia
34. Human immunodeficiency virus (HIV)-positive sera obtained shortly after seroconversion neutralize autologous HIV type 1 isolates on primary macrophages but not on lymphocytes
35. Biological and virologic characteristics of primary HIV infection
36. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes
37. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein
38. + effector cells armed in vivo with cytophilic antibody
39. Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection